论文部分内容阅读
目的探讨两种不同雾化吸入法在慢性咽炎治疗中的临床效果。方法 124例慢性咽炎患者,随机分成观察组与对照组,各62例。观察组患者给予康复新液联合地塞米松雾化吸入治疗,对照组患者给予庆大霉素、地塞米松磷酸钠及糜蛋白酶联合雾化吸入治疗,比较两组患者的临床疗效。结果观察组患者临床治疗总有效率为88.7%,明显高于对照组的75.8%,差异具有统计学意义(P<0.05)。结论康复新液与地塞米松联合应用的雾化吸入治疗方案临床效果显著,可以作为慢性咽炎的首选治疗方法。
Objective To investigate the clinical effects of two different inhalation methods in the treatment of chronic pharyngitis. Methods 124 patients with chronic pharyngitis were randomly divided into observation group and control group, with 62 cases in each. Patients in the observation group were treated with Kangfuxin Solution combined with dexamethasone nebulized inhalation. Patients in the control group were treated with gentamycin, dexamethasone sodium phosphate and chymotrypsin combined with atomizing inhalation. The clinical efficacy was compared between the two groups. Results The total effective rate of clinical treatment in observation group was 88.7%, which was significantly higher than that in control group (75.8%), the difference was statistically significant (P <0.05). Conclusion The therapeutic effect of Fufangxinye and dexamethasone combined with nebulized inhalation therapy is significant and can be used as the first choice of treatment for chronic pharyngitis.